- Conditions
- Intracranial Hemorrhage, Ventriculitis, Intracranial Abscess
- Interventions
- IRRAflow® CNS (Active Fluid Exchange) System
- Device
- Lead sponsor
- Christopher P Kellner
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 250 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2031
- U.S. locations
- 1
- States / cities
- New York, New York
Source: ClinicalTrials.gov public record
Updated Oct 27, 2025 · Synced May 22, 2026, 4:12 AM EDT